Q32 Bio QTTB
NASDAQ QTTB
$8.27 -1.26 (-13.22%)
At close: Sep 30, 2026 · 4:00 PM EDT

Q32 Bio (QTTB) EV to EBITDA (2025 - 2026)

Updated

Q32 Bio's EV to EBITDA was 8.97 in Q2 2026, up 353.2% from the prior quarter.

Analysis

Q32 Bio (QTTB) EV to EBITDA (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Q32 Bio's EV to EBITDA was 1.29 through Jun 30, 2026; for FY2025, it came in at -0.32.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Q32 Bio 226.21 Mn -48.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.97
Mar 31, 2026 1.98
Dec 31, 2025 -0.32
API Access

Q32 Bio EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=QTTB&period=max&api_key=YOUR_API_KEY